Inhibrx Biosciences (INBX) Earnings Date & Reports

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

INBX is expected to report earnings to fall 44.64% to -154 cents per share on August 19

Inhibrx Biosciences INBX Stock Earnings Reports

Q2'25

Est.

$-1.55

Q1'25

Missed

by $1.39

Q4'24

Missed

by $1.65

Q3'24

Missed

by $1.36

Q2'24

Beat

by $127.00

The last earnings report on May 14 showed earnings per share of -279 cents, missing the estimate of -140 cents. With 393.15K shares outstanding, the current market capitalization sits at 208.89M.

View a ticker or compare two or three

Compare

INBX